AIG Gets Ready to Play Offense
AIG has spent the last four years selling off assets -- more than $50 billion all told. That might be about to change. AIG Chairman Steve Miller tells Bloomberg TV that the firm is ready to go on the offensive. He says the AIG is now focused on growth and returning capital to investors.
Deals of the Day: Corporate Profits Are Up, But Corporate Taxes Fall
Deals of the Day compiles this morning’s biggest news about mergers and acquisitions, banking, bankruptcy and more. Catch us on Twitter, @WSJDealJournal.
Why Glen-X Got a Thumbs Up From the Markets
The markets like Glen-X. What are some possible reasons for the markets’ giddiness?
Failed Trades: The Last Year in Exchange M&A
The European Commission blocked the merger of Deutsche Börse and NYSE Euronext, officially ending the two firms' vision of creating a giant global exchange operator.
Deals of the Day: Meet Divesh Makan — Adviser to Social-Media Stars
Deals of the Day compiles this morning’s biggest news about mergers and acquisitions, markets doomsday, private equity and more.
Deals of the Day: BofA Shakes Up Investment Bank, Again
Deals of the Day compiles this morning’s biggest news about mergers and acquisitions, banking, bankruptcy and more.
Facebook IPO: Is Another VC Boom on the Horizon?
Facebook’s upcoming IPO is likely to rain riches across Silicon Valley.
Morgan Stanley Close to Winning Facebook Deal
Here are the headlines crossing Dow Jones Newswires right now: Morgan Stanley Close To Winning Facebook Deal -- source; Facebook Now Looking at Valuation of $75 Billion to $100 billion - source
How Apple Is Like Goldman
That’s the topic David Weidner decided to tackle in his column today.
Barclays’s Diamond: Bankers ‘Get It’ on Pay
It’s that time of year when banks dole out bonuses. And this year, it's not a joyous time.
Deal Profile: Roche Makes Hostile Offer for Illumina
Swiss drug-giant Roche made a $6 billion hostile offer Wednesday for Illumina, an expensive and risky bet that genetic mapping will soon be common practice in doctors offices and hospitals.
SEC Puts Private Equity Under the Enforcement Microscope
The Securities and Exchange Commission has private equity squarely in its enforcement crosshairs.
